Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

NYSE Arca Biotech Index First Trust (FBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fund basics

See More

Price Performance

See More
Period Period Low Period High Performance
1-Month
100.90 +6.45%
on 04/11/17
107.52 -0.10%
on 04/28/17
+2.98 (+2.85%)
since 03/28/17
3-Month
91.71 +17.12%
on 01/31/17
108.01 -0.56%
on 03/21/17
+13.28 (+14.11%)
since 01/27/17
52-Week
83.10 +29.25%
on 06/27/16
108.01 -0.56%
on 03/21/17
+13.86 (+14.82%)
since 04/28/16

Most Recent Stories

More News
The Implied Analyst 12-Month Target For FBT

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...

FBT : 107.41 (+0.53%)
Implied FBT Analyst Target Price: $122

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...

FBT : 107.41 (+0.53%)
Time to Buy Biotech ETF?

After a painful 2016, biotech stocks are recovering this year. What lies ahead?

PBE : 43.10 (+0.21%)
FBT : 107.41 (+0.53%)
BBH : 121.99 (+0.62%)
XBI : 71.44 (+0.35%)
Time to Buy Biotech ETFs?

After a painful 2016, biotech stocks are recovering this year. What lies ahead?

PBE : 43.10 (+0.21%)
IBB : 297.64 (+0.38%)
FBT : 107.41 (+0.53%)
BBH : 121.99 (+0.62%)
XBI : 71.44 (+0.35%)
Healthcare ETFs in Focus on Obamacare Replacement Plan

House Republicans have released the long-awaited bill to repeal and replace Obama's signature healthcare law last evening. This will unwind much of the law over the next three years.

XHS : 58.59 (+0.31%)
XLV : 75.50 (+0.27%)
VHT : 140.13 (+0.26%)
IHF : 137.44 (+0.57%)
IHE : 153.27 (-0.21%)
IBB : 297.64 (+0.38%)
PPH : 55.20 (-0.27%)
BBH : 121.99 (+0.62%)
XPH : 43.06 (-0.09%)
PJP : 60.65 (-0.02%)
FXH : 63.58 (+0.82%)
IYH : 158.60 (+0.25%)
FBT : 107.41 (+0.53%)
XBI : 71.44 (+0.35%)
Healthcare ETFs in Focus on Obamacare Replacement Plan

House Republicans have released the long-awaited bill to repeal and replace Obama's signature healthcare law last evening. This will unwind much of the law over the next three years.

XHS : 58.59 (+0.31%)
XLV : 75.50 (+0.27%)
VHT : 140.13 (+0.26%)
IHF : 137.44 (+0.57%)
IHE : 153.27 (-0.21%)
IBB : 297.64 (+0.38%)
PPH : 55.20 (-0.27%)
BBH : 121.99 (+0.62%)
XPH : 43.06 (-0.09%)
PJP : 60.65 (-0.02%)
FXH : 63.58 (+0.82%)
IYH : 158.60 (+0.25%)
FBT : 107.41 (+0.53%)
XBI : 71.44 (+0.35%)
Biotech ETFs Powered by Q4 Earnings

Improved earnings are driving the biotech space and ETFs higher over the past 10 days.

CELG : 124.05 (+0.06%)
ILMN : 184.86 (+0.61%)
IBB : 297.64 (+0.38%)
VRTX : 118.30 (+0.75%)
FBT : 107.41 (+0.53%)
BBH : 121.99 (+0.62%)
GILD : 68.55 (-0.04%)
AMGN : 163.32 (+0.37%)
BIIB : 271.21 (-1.94%)
Biotech ETFs Powered by Q4 Earnings

Improved earnings are driving the biotech space and ETFs higher over the past 10 days.

CELG : 124.05 (+0.06%)
ILMN : 184.86 (+0.61%)
IBB : 297.64 (+0.38%)
VRTX : 118.30 (+0.75%)
FBT : 107.41 (+0.53%)
BBH : 121.99 (+0.62%)
GILD : 68.55 (-0.04%)
AMGN : 163.32 (+0.37%)
BIIB : 271.21 (-1.94%)
What Lies Ahead for Biotech ETFs in Trump Era?

Despite political risks, there are many factors supporting growth in the biotech sector.

PBE : 43.10 (+0.21%)
IBB : 297.64 (+0.38%)
FBT : 107.41 (+0.53%)
BBH : 121.99 (+0.62%)
XBI : 71.44 (+0.35%)
What Lies Ahead for Biotech ETFs in Trump Era?

Despite political risks, there are many factors supporting growth in the biotech sector.

PBE : 43.10 (+0.21%)
IBB : 297.64 (+0.38%)
FBT : 107.41 (+0.53%)
BBH : 121.99 (+0.62%)
XBI : 71.44 (+0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Fund Summary

The First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. The NYSE Arca Biotechnology Index is an equal dollar weighted...

See More

Support & Resistance

2nd Resistance Point 108.28
1st Resistance Point 107.84
Last Price 107.41
1st Support Level 106.65
2nd Support Level 105.90

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.